LIVE SESSION BRIEF Medical Instruments & Supplies $68M Cap Quant: HOLD

Daxor Corporation (DXR) — Live Session & Technical Brief

Updated Nov 16, 2026 8:07 PM ET · Prev Close $8.48

Pro Workspace
Last Session Price
$8.36 -1.47%
-$0.12 vs $8.48 prior close
Intraday Range
$8.36 – $8.72
Open $8.50
Relative Volume
0.16x Avg
1,936 sh
52-Week Range
$8.24 – $14.76
Benchmark Alpha
+0.44% vs SPY
+1.20% vs QQQ
20-Session Trend -14.3%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-1.47%) in Medical Instruments & Supplies

Daxor Corporation (DXR) is trading within a tight intraday band at $8.36 (-1.47%, 0.16x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, DXR is trading in line with the S&P 500 (+0.44% alpha). 14-day RSI stands at 31.2, keeping momentum in a bearish regime.

NEWS 70% Weight
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26

FDA-cleared BVA technology delivers lab-accurate precision to optimize cardiovascular service lines, reduce 30-day readmissions, and lower cost of care. Key Highlights Commercial Acceleration Daxor showcasing its next-ge

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($8.36) trades relative to 20-day SMA ($8.91) and 50-day SMA ($10.07).

Volume Confirmation
LOW VOLUME (0.16x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

DXR trading in line with the S&P 500 (+0.44% alpha)
DXR Session
-1.47%
$8.36
S&P 500 (SPY)
-1.91%
$739.95
Nasdaq 100 (QQQ)
-2.67%
$661.75
Healthcare (XLV)
-0.51%
$187.88
Alpha vs SPY: +0.44% Alpha vs QQQ: +1.20% Alpha vs XLV: -0.96%

Recent DXR Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$8.04
Short-term support band
Upper Bound
$8.68
Short-term resistance band
Key Inflection Level
$8.91 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $8.91 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (DXR)

BEARISH MA TREND
RSI (14)
31.2
Bearish
20-Day SMA
$8.91
Below 20d
50-Day SMA
$10.07
Below 50d
MACD Signal
Bullish
MACD -0.45
ADX (14)
41.3
Strong trend
10d Momentum
-0.65
Soft 10-day momentum

Retail & Crowd Sentiment

Quiet
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

StockTwits shows bullish sentiment for $DXR with one user predicting a strong performance. No recent news articles were found.

About Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the Bva-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical …

Sector
Healthcare
Market Cap
$68M
Forward P/E
79.9x
Employees
750

Get Instant DXR Catalyst Alerts

Receive an email alert when DXR triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

DXR Session & Catalyst FAQ

Why is DXR stock trading near flat today?

Daxor Corporation (DXR) is trading within a tight intraday band at $8.36 (-1.47%, 0.16x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, DXR is trading in line with the S&P 500 (+0.44% alpha). 14-day RSI stands at 31.2, keeping momentum in a bearish regime.

Is DXR stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.16x relative volume (low participation). Our multi-factor model currently rates DXR as HOLD. Review full valuation, quality, and timing signals on the DXR Buy or Sell Decision Brief →

What is DXR's intrinsic value and expected trading range?

At $8.36, DXR's modeled 1-to-3 session range is $8.04 – $8.68, with a key inflection level at $8.91 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the DXR Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for DXR?

RSI at 31.2 reflects soft below-midline momentum. DXR trades at $8.36 relative to its 20-day SMA ($8.91) and 50-day SMA ($10.07), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs